πŸ‡ΊπŸ‡Έ FDA
Patent

US 6455035

Angiopoietins and methods of use thereof

expired A61KA61K38/1891

Quick answer

US patent 6455035 (Angiopoietins and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/1891